We know you might be overwhelemed with virus news– and next week, we’ll switch the theme up. For now, we wanted to send three updates your way about Coronavirus and how it overlaps with our readers.
How could this type of specialist lead the way to protecting vulnerable groups from COVID-19?[one_half]
Orphan Drug Designation is typically used to help rare disease drug development. COVID-19 is unfortunately very common– why has it received this label and what are the potential downsides?
Right now immunocompromised groups are talked about a lot. However, they’ve always been here around us– and have always needed communal effort to stay safe.